116 related articles for article (PubMed ID: 17691106)
1. Getting a first clue about SPRED functions.
Bundschu K; Walter U; Schuh K
Bioessays; 2007 Sep; 29(9):897-907. PubMed ID: 17691106
[TBL] [Abstract][Full Text] [Related]
2. Distinct requirements for the Sprouty domain for functional activity of Spred proteins.
King JA; Straffon AF; D'Abaco GM; Poon CL; I ST; Smith CM; Buchert M; Corcoran NM; Hall NE; Callus BA; Sarcevic B; Martin D; Lock P; Hovens CM
Biochem J; 2005 Jun; 388(Pt 2):445-54. PubMed ID: 15683364
[TBL] [Abstract][Full Text] [Related]
3. The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.
Miyoshi K; Wakioka T; Nishinakamura H; Kamio M; Yang L; Inoue M; Hasegawa M; Yonemitsu Y; Komiya S; Yoshimura A
Oncogene; 2004 Jul; 23(33):5567-76. PubMed ID: 15184877
[TBL] [Abstract][Full Text] [Related]
4. FGF signal interpretation is directed by Sprouty and Spred proteins during mesoderm formation.
Sivak JM; Petersen LF; Amaya E
Dev Cell; 2005 May; 8(5):689-701. PubMed ID: 15866160
[TBL] [Abstract][Full Text] [Related]
5. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M
Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141
[TBL] [Abstract][Full Text] [Related]
6. The VASP-Spred-Sprouty domain puzzle.
Bundschu K; Walter U; Schuh K
J Biol Chem; 2006 Dec; 281(48):36477-81. PubMed ID: 16987806
[TBL] [Abstract][Full Text] [Related]
7. Eve-3: a liver enriched suppressor of Ras/MAPK signaling.
King JA; Corcoran NM; D'Abaco GM; Straffon AF; Smith CT; Poon CL; Buchert M; I S; Hall NE; Lock P; Hovens CM
J Hepatol; 2006 Apr; 44(4):758-67. PubMed ID: 16478641
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the receptor FGFRL1 with the negative regulator Spred1.
Zhuang L; Villiger P; Trueb B
Cell Signal; 2011 Sep; 23(9):1496-504. PubMed ID: 21616146
[TBL] [Abstract][Full Text] [Related]
9. Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras/extracellular signal-regulated kinase (ERK) pathway.
Quintanar-Audelo M; Yusoff P; Sinniah S; Chandramouli S; Guy GR
J Biol Chem; 2011 Jul; 286(26):23102-12. PubMed ID: 21531714
[TBL] [Abstract][Full Text] [Related]
10. Characterization and binding affinities of SmLANP: a new Schistosoma mansoni member of the ANP32 family of regulatory proteins.
Pinheiro CS; Staub O; Mulvenna J; Loukas A; Jones MK; Rabelo EM
Mol Biochem Parasitol; 2009 Jun; 165(2):95-102. PubMed ID: 19428656
[TBL] [Abstract][Full Text] [Related]
11. The Sprouty/Spred family as tumor suppressors: Coming of age.
Kawazoe T; Taniguchi K
Cancer Sci; 2019 May; 110(5):1525-1535. PubMed ID: 30874331
[TBL] [Abstract][Full Text] [Related]
12. Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness.
Inoue H; Kato R; Fukuyama S; Nonami A; Taniguchi K; Matsumoto K; Nakano T; Tsuda M; Matsumura M; Kubo M; Ishikawa F; Moon BG; Takatsu K; Nakanishi Y; Yoshimura A
J Exp Med; 2005 Jan; 201(1):73-82. PubMed ID: 15630138
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific Spred-2 promoter activity characterized by a gene trap approach.
Bundschu K; Gattenlöhner S; Knobeloch KP; Walter U; Schuh K
Gene Expr Patterns; 2006 Mar; 6(3):247-55. PubMed ID: 16378760
[TBL] [Abstract][Full Text] [Related]
14. Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation.
Momeny M; Khorramizadeh MR; Ghaffari SH; Yousefi M; Yekaninejad MS; Esmaeili R; Jahanshiri Z; Nooridaloii MR
Eur J Pharmacol; 2008 Sep; 591(1-3):13-20. PubMed ID: 18599034
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation.
Kato R; Nonami A; Taketomi T; Wakioka T; Kuroiwa A; Matsuda Y; Yoshimura A
Biochem Biophys Res Commun; 2003 Mar; 302(4):767-72. PubMed ID: 12646235
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
17. Properties of an ezrin mutant defective in F-actin binding.
Saleh HS; Merkel U; Geissler KJ; Sperka T; Sechi A; Breithaupt C; Morrison H
J Mol Biol; 2009 Jan; 385(4):1015-31. PubMed ID: 19084535
[TBL] [Abstract][Full Text] [Related]
18. Spatial regulation of Raf kinase signaling by RKTG.
Feng L; Xie X; Ding Q; Luo X; He J; Fan F; Liu W; Wang Z; Chen Y
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14348-53. PubMed ID: 17724343
[TBL] [Abstract][Full Text] [Related]
19. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of Cdc42 through the GAP domain of RLIP participates in remodeling of the actin cytoskeleton and is involved in Xenopus gastrulation.
Boissel L; Houssin N; Chikh A; Rynditch A; Van Hove L; Moreau J
Dev Biol; 2007 Dec; 312(1):331-43. PubMed ID: 17950267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
